Identifying the cell type-specific genetic networks that respond to injury and inflammation, such as Stat1, will be key to rationally designing pro-regenerative therapies in chronic progression of neuroinflammatory diseases such as MS. Here, STAT1 is linked to myeloid sarcoma.